Octreotide Teva B.V. (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotide Teva B.V., is a somatostatin analog presented as a sterile solution for subcutaneous injection use. It regulates hormone secretion and is employed in the management of hormone‑secreting tumours and related complications.

GNH USA supplies Octreotide Teva B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Octreotide Teva B.V. acts through the somatostatin pathway of neuro‑endocrine diseases and the treatment of h  ​    a   a  a  g .

-   t  ":   g "  . -   " " " " " " ". -  " " "" ". -  g